🇺🇸 Depo-Medrone in United States

158 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Malaise — 33 reports (20.89%)
  2. Confusional State — 20 reports (12.66%)
  3. Diarrhoea — 19 reports (12.03%)
  4. Nausea — 14 reports (8.86%)
  5. Vomiting — 14 reports (8.86%)
  6. Pruritus — 13 reports (8.23%)
  7. Lethargy — 12 reports (7.59%)
  8. Dizziness — 11 reports (6.96%)
  9. Dyspnoea — 11 reports (6.96%)
  10. Erythema — 11 reports (6.96%)

Source database →

Depo-Medrone in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Depo-Medrone approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Depo-Medrone in United States?

Keele University is the originator. The local marketing authorisation holder may differ — check the official source linked above.